Article · 2019
Editor
Dr Azza A Ali
Professor and Head of Pharmacology and Toxicology Department, Al-Azhar University, Egypt
About
As published by the journal they serve.
Prof. Azza A Ali has completed her PhD specialized in Pharmacology and Toxicology from Faculty of Pharmacy, Cairo University. Her postdoctoral studies included different scientific aspects related to her specialization field with giving especial interest to researches of neuropharmacology and psychopharmacology; she also developed research line of behavioral pharmacology in Egypt. She is member of many scientific societies in Egypt and of (AAPS) American Association of Pharmaceutical Scientists (2002) and published more than 35 papers in reputed journals, supervised and discussed more than 50 PhD and MSc thesis and actively participated by oral and posters presentations at many international conferences especially on Alzheimers disease & Dementia. Now she is a Head of Pharmacology and Toxicology Department at Al-Azhar University and she sacrifices great effort hoping to find real treatment that can prevent or delay the progression of Alzheimers disease especially in the high-risk individuals focusing on depression, stress and malnutrition.
Research interests
Journals they serve
The seats these journals name them in.
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2019
The potential role of propolis on the therapeutic effectiveness of L-dopa during development of parkinsonism in rats
Article · 2019
Protection against development of parkinsonism in rats: Impact of nutrients versus the deleterious effects of manganese
Article · 2019
Comparison between the efficacies of pomegranate with different combinations against development of parkinsonism using rotenone model in rats
Article · 2019
Parkinson’s disease and Dementia: Induction and protection
Article · 2017
Impact of vinpocetine on the therapeutic effectiveness of L-DOPA using rat model of Parkinson's disease
Article · 2017
Modulatory effects of bisphenol A, caffeine, epigallocatechin-3-gallate and their combinations against parkinsonism in rats
Article · 2017
Comparative study on the potential role of cocoa, epigallocatechin-3- gallate, coenzyme Q10 and their combination against manganese-induced parkinsonian like syndrome in rats
Article · 2017
Impact of vinpocetine on the therapeutic effectiveness of L-DOPA using rat model of ParkinsonâÂ?²s Disease
Article · 2017
Effect of anakinra on cirrhotic cardiomyopathic rats
Article · 2016
Comparative Study on the Influence of Epigallocatechin-3-gallat e and/ or Coenzyme Q10 against Alzheimer's disease Induced by Aluminium in Normally-Fed and Protein Malnourished Rats
Article · 2016
Risk factors in induction and progression of Alzheimer’s disease: Impact on protection and diseasemodifying factors
Article · 2016
The Role of Mental and Physical Activities against Development of AlzheimerâÂ?²s disease in Socialized and Isolated Rats
Article · 2016
Study on Social Isolation as a Risk Factor in Alzheimer′s disease
Article · 2016
Risk factors in induction and progression of Alzheimer′s disease: Impact on protection and diseasemodifying factors
Article · 2015
The potential effect of Caffeine and Nicotine co-administration on the induction of Alzheimer’s disease
Article · 2015
Comparative study on the influence of Epigallocatechin-3-gallate and/ or Coenzyme Q10 on induction of Alzheimers disease in normally-fed and protein malnourished rats
Article · 2015
The potential effect of Epigallocatechin-3-gallate alone or in combination with Vitamin E and selenium on Alzheimers disease induced by aluminum in rats
Article · 2015
Modeling stages of Alzheimers disease induced by different doses of Aluminum in rats: Focus on progression of the disease in response to time
Article · 2015
The potential effect of Caffeine and Nicotine co-administration on the induction of Alzheimers disease
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
